The International Center for Retinitis Pigmentosa, founded in 1992 by Prof. Dr. Orfilio Peláez Molina, has been dedicated for more than forty years to studying the therapeutic possibilities to stop the progression of Retinitis Pigmentosa.
The building where the International Center for Retinitis Pigmentosa operates has its origins in the late 40s of the 20th century, with the company being located there. the Nuestra Señora del Carmen clinic, owned by the Valle brothers. Later it became a mutual institution and then a multipurpose clinic, which included maternal and child services.
After the revolutionary triumph of 1959, it became a specialized public service, open to all social sectors.
The International Center for Retinitis Pigmentosa Camilo Cienfuegos has the mission of providing specialized medical care services for the diagnosis and treatment of ophthalmological diseases such as Retinitis Pigmentosa, Myopia, Hyperopia, Astigmatism, Cataract, Glaucoma, Strabismus, Corneal Diseases, Retinopathy and other ocular pathologies. It is an international reference center.
Due to the severe limitation that it represents for those who suffer from Retinitis Pigmentosa, the vast majority of whom are young, a team of Cuban scientists provides ophthalmolomatic care. specialized medicine for the diagnosis of eye diseases and especially treatment of Retinitis Pigmentosa.
The International Retinitis Pigmentosa Center provides a therapeutic alternative for the prevention of Retinitis Pigmentosa that is based on the accumulated experience and research carried out over several years. , by a group of specialists led by the eminent Cuban scientist, recognized nationally and internationally, Professor Doctor Orfilio Peláez Molina (1923-2001).
The work verticalized by Cuban scientists towards the study of Retinitis Pigmentosa would be the genesis of the Cuban Society of Retinitis Pigmentosa. It is precisely at the beginning of the 90s when the National Group and then the Retinitis Pigmentosa Society</strong > were created; Such background, added to the support of the National Health System of Cuba allowed the formation of a National Program for Retinitis Pigmentosa, which from a holistic approach covers the research phases, diagnosed aesthetic and study of the family, as well as as a coherent platform for clinical, basic and epidemiological research.
In its more than 20 years, the International Center for Retinitis Pigmentosa reports having treated, between outpatients and inpatients, more than 99,802 patients, from about 109 countries. ses, of which the highest percentage corresponds to patients with Retinitis Pigmentosa.
On its seven floors, the architectural facility has 60 comfortably equipped rooms for the satisfaction of patients and families.
Likewise, it has consultation and clinical research areas, three operating rooms equipped with cutting-edge technology, two dedicated to ophthalmological surgery in general and another to ophthalmological surgery. refractive with excimer and femtosecond laser.
The treatment applied forRetinitis Pigmentariaconsists of performing a surgical technique associated with the application of ozone therapy, electrostimulation, vitamin therapy and therapy with trace elements. This surgery implants orbital vascular fatty tissue in the suprachoroidal space, a structure rich in blood vessels.
In Cuba there is a National Program of care for Retinitis Pigmentosa, directed by Prof. Peláez that covers all the provinces of the country, where more than 6,000 patients have been treated and which has allowed us to know that 3.5 per 10,000 inhabitants suffer from the disease.
All these years of experience and studies are at your disposal at the "Camilo Cienfuegos" International Center for Retinitis Pigmentosa, where around 4,365 patients from 78 countries have been treated. Other ophthalmological pathologies are also treated, such as: Retinal Dystrophies, diseases of the Macula, eye diseases associated with Retinitis Pigmentosa, Cataract, Glaucoma, Myopia, other Ametropia.
This novel therapeutic, which is applied according to the stage of the Retinitis Pigmentosa disease in patients, has obtained satisfactory results. As evidence of success, in more of the 10,000 cases treated to date, 78% stopped the progression of the disease, 16% expanded their field and visual acuity and only 6% did not show satisfactory results. This effective and exclusive treatment to stop the progression of Retinitis Pigmentosa is offered at the Camilo Cienfuegos International Center for Retinitis Pigmentosa in Havana.
Medical Services Providers
